What is the half-life of Wellbutrin (bupropion)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Half-Life of Bupropion (Wellbutrin)

The mean elimination half-life of bupropion is 21 (±9) hours, as indicated in the FDA drug label. 1

Pharmacokinetic Profile of Bupropion

Bupropion undergoes extensive metabolism in the body, resulting in three active metabolites with their own half-lives:

  • Parent drug (bupropion): 21 (±9) hours 1
  • Hydroxybupropion (primary active metabolite): approximately 20 (±5) hours 1
  • Threohydrobupropion: approximately 37 (±13) hours 1
  • Erythrohydrobupropion: approximately 33 (±10) hours 1

Metabolite Activity and Concentrations

The metabolites of bupropion contribute significantly to its clinical effects:

  • Hydroxybupropion is approximately 50% as potent as bupropion, but its plasma concentration at steady state is about 7 times higher than the parent drug 1
  • Threohydrobupropion and erythrohydrobupropion are about 5-fold less potent than bupropion 1
  • At steady state, the AUC (area under the curve) of hydroxybupropion is approximately 13 times that of bupropion 1

Formulation Differences

The pharmacokinetic profile varies slightly between different formulations of bupropion:

  • Immediate Release (IR): Peak plasma concentration reached in approximately 1.5 hours 2
  • Sustained Release (SR): Peak plasma concentration reached in approximately 3 hours 2
  • Extended Release (XL): Peak plasma concentration reached in approximately 5 hours 2

Despite these differences in absorption rates, all three formulations are bioequivalent in terms of overall drug exposure 2.

Clinical Implications

The relatively long half-life of bupropion and its metabolites has important clinical implications:

  • Allows for once-daily dosing with the XL formulation 3
  • Steady-state plasma concentrations are typically reached within 8 days of starting treatment 1
  • The extended half-life of the metabolites means they accumulate to higher concentrations than the parent drug during chronic dosing 1
  • When discontinuing bupropion, a gradual tapering approach is recommended to minimize withdrawal symptoms 3

Factors Affecting Half-Life

Several factors can influence the half-life and metabolism of bupropion:

  • Hepatic impairment: May prolong half-life and increase drug exposure 3
  • Renal impairment: Requires dose adjustment, with half the normal dose recommended for moderate to severe renal impairment 3
  • Drug interactions: Medications affecting CYP2B6 (the primary enzyme responsible for forming hydroxybupropion) may alter bupropion metabolism 3, 1

Understanding the half-life of bupropion and its metabolites is essential for appropriate dosing, monitoring for drug interactions, and managing treatment discontinuation.

References

Guideline

Bupropion Therapy Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.